Suscribirse

Psychological impact of the SARS-CoV-2 outbreak on the staff of a French hospital - 09/03/21

Doi : 10.1016/j.idnow.2021.01.007 
C. Flateau a, , C. Noël b, A. Bonnafoux c, E. Fuentes c, A. de Pontfarcy a, S. Diamantis a
a Service des maladies infectieuses, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France 
b Équipe mobile opérationnelle d’hygiène, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France 
c Pôle médecine, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Two months after the outbreak of SARS-CoV-2, the hospital staff displayed symptoms of anxiety, depression and post-traumatic stress disorder.
Some professionals initiated or increased previous treatment with sleeping pills or anxiolytics.
Several modifiable factors associated with the psychological impact of SARS-CoV-2 were identified.
The observance of transmission preventive measures was not associated with the psychological impact of SARS-CoV-2.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

The outbreak of SARS-CoV-2 has resulted in anxiety, depression and post-traumatic stress disorder (PTSD) among hospital staff. The factors associated with this psychological impact remain to be determined.

Methods

A cross-sectional study using an online questionnaire completed by the staff of a French hospital, two months after the SARS-CoV-2 outbreak.

Results

Among the 353 participants (of whom 67% were healthcare professionals), 32% had symptoms of anxiety, 16% of depression and 16% of PTSD. Eleven per cent had initiated or increased treatment with sleeping pills, and 6% with anxiolytics. In a multivariate analysis, factors independently associated with anxiety were: change of professional team, having a relative infected by SARS-CoV-2 and a new/increased treatment with sleeping pills or anxiolytics. The only factor associated with depression was the feeling of risk during professional practice. The factors associated with PTSD were: having a relative infected by SARS-CoV-2, the feeling of risk during professional practice, the increase in smoking and treatment with sleeping pills. The observance of transmission preventive measures (TPM) was not associated with the psychological impact of SARS-CoV-2. A personal history of SARS-CoV-2 infection and age<36 years were associated with insufficient use of protective equipment. Age<36 years, and being a healthcare professional were associated with the non-observance of social distancing.

Conclusion

The hospital staff displayed psychological consequences, resulting in the use of anxiolytics and sleeping pills. Belonging to a group with low-risk of severe disease was associated with lower observance of TPM.

El texto completo de este artículo está disponible en PDF.

Keywords : Epidemic, SARS-CoV-2, Healthcare professionals, Depression, Anxiety, Post-traumatic stress disorder, Personal protective equipment


Esquema


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 51 - N° 2

P. 187-193 - mars 2021 Regresar al número
Artículo precedente Artículo precedente
  • First evaluation of the automated-multiplex-PCR Unyvero ITI G2 cartridge for rapid diagnosis of osteo-articular infections
  • E. Lafeuille, S. Jauréguiberry, F. Devriese, E. Sadowski, E. Fourniols, A. Aubry, the CRIOAC Pitié-Salpêtrière
| Artículo siguiente Artículo siguiente
  • The additional contribution of second nasopharyngeal PCR to COVID-19 diagnosis in patients with negative initial test
  • B. Kayaaslan, A. Kaya Kalem, F. Eser, I. Hasanoglu, R. Guner

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.